Engineers Gate Manager LP Ptc Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 48,029 shares of PTCT stock, worth $1.88 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
48,029
Previous 94,285 49.06%
Holding current value
$1.88 Million
Previous $2.88 Million 38.22%
% of portfolio
0.04%
Previous 0.07%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$30.39 - $37.66 $1.41 Million - $1.74 Million
-46,256 Reduced 49.06%
48,029 $1.78 Million
Q2 2024

Aug 14, 2024
BUY
$24.69 - $40.12 $705,615 - $1.15 Million
28,579 Added 43.5%
94,285 $2.88 Million
Q1 2024

May 15, 2024
SELL
$24.15 - $31.95 $91,987 - $121,697
-3,809 Reduced 5.48%
65,706 $1.91 Million
Q4 2023

Feb 14, 2024
BUY
$18.07 - $29.37 $395,949 - $643,555
21,912 Added 46.03%
69,515 $1.92 Million
Q3 2023

Nov 14, 2023
BUY
$22.41 - $41.99 $894,943 - $1.68 Million
39,935 Added 520.8%
47,603 $1.07 Million
Q2 2023

Aug 14, 2023
BUY
$40.4 - $59.1 $309,787 - $453,178
7,668 New
7,668 $311,000
Q4 2022

Feb 14, 2023
BUY
$33.53 - $54.79 $15,356 - $25,093
458 Added 4.87%
9,864 $376,000
Q3 2022

Nov 14, 2022
BUY
$41.85 - $53.85 $110,400 - $142,056
2,638 Added 38.98%
9,406 $472,000
Q2 2022

Aug 15, 2022
SELL
$25.6 - $45.23 $6,041 - $10,674
-236 Reduced 3.37%
6,768 $271,000
Q1 2022

May 16, 2022
BUY
$33.33 - $44.6 $233,443 - $312,378
7,004 New
7,004 $261,000
Q4 2021

Feb 14, 2022
SELL
$35.36 - $41.86 $958,821 - $1.14 Million
-27,116 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$37.01 - $44.74 $1 Million - $1.21 Million
27,116 New
27,116 $1.01 Million
Q2 2021

Aug 16, 2021
SELL
$37.95 - $49.37 $214,797 - $279,434
-5,660 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$46.8 - $68.92 $203,018 - $298,974
-4,338 Reduced 43.39%
5,660 $268,000
Q4 2020

Feb 16, 2021
SELL
$47.96 - $67.64 $7,241 - $10,213
-151 Reduced 1.49%
9,998 $610,000
Q3 2020

Nov 16, 2020
BUY
$45.41 - $57.07 $460,866 - $579,203
10,149 New
10,149 $474,000
Q2 2020

Aug 17, 2020
SELL
$42.56 - $54.98 $716,029 - $924,983
-16,824 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$32.37 - $59.36 $306,317 - $561,723
9,463 Added 128.56%
16,824 $751,000
Q4 2019

Feb 14, 2020
SELL
$32.22 - $50.07 $541,650 - $841,726
-16,811 Reduced 69.55%
7,361 $354,000
Q3 2019

Nov 14, 2019
BUY
$33.82 - $48.17 $817,497 - $1.16 Million
24,172 New
24,172 $817,000

Others Institutions Holding PTCT

# of Institutions
223
Shares Held
78.1M
Call Options Held
144K
Put Options Held
58.7K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email